Editorial: Design, Synthesis, and Preclinical Testing of Innovative Anti-Cancer Compounds With a High Level of Selectivity of Action and Low Toxicity

Front Mol Biosci. 2022 Apr 7:9:859821. doi: 10.3389/fmolb.2022.859821. eCollection 2022.

Authors

Ana Maria Da Costa Ferreira¹, Regine Schneider-Stock², Francesca Aiello³

Affiliations

¹ Department of Chemistry, University of São Paulo, São Paulo, Brazil.
² Institute of Pathologie, Erlanger University, Erlanger, Germany.
³ Department of Pharmacy, University of Calabria, Cosenza, Italy.

No abstract available

Keywords: anti-cancer (anticancer) drugs; innovative compounds; metabolomics; selectivity; strategies to improve biological activity.

Publication types

Editorial